
Among two primary types of lung cancers, Small cell lung cancer is a rare and rapidly spreading type. While anyone might be affected, those who have smoked tobacco for a long time are usually the ones who are affected.
Type of Small Cell Lung Cancer (SCLC)
There are two major types of SCLC
What is the Importance of Timely Treatment?
Timely treatment of Small Cell Lung Cancer (SCLC) is essential for several reasons:
Small Cell Lung Cancer (SCLC) is better known for its aggressiveness and rapid progression. Here are some common symptoms:
Although smoking is the leading cause of small cell lung cancer (SCLC), there are several other risk factors to take into account.
Advanced medicines and technologies are changing the small cell lung cancer (SCLC) treatment landscape in the United Arab Emirates (UAE). Combining immunotherapy drugs with platinum-coated chemotherapy, which has demonstrated better survival rates, is the standard treatment for extensive-stage SCLC. Protein checkpoint inhibitors are examples of emerging therapies that are currently being researched. More personalised treatment strategies are being made possible by research into SCLC subtypes.
There are a few things you can do to lower your risk of developing Small Cell Lung Cancer (SCLC), particularly of the bladder, even if it is not always preventable:
Treatment options for Small Cell Lung Cancer (SCLC) differ based on the type and stage of the disease and the patient's overall health. The following are a few current treatments:
Lobectomy: Elimination of a lung lobe. The most popular procedure for SCLC in its early stages is this one.
Wedge Resection: This removes a small section of the tumour.
Segmentectomy: This is the Removal of a more prominent lung segment but not the entire lobe. Usually, this is applied to individuals with lung impairment or early-stage cancer.
Radiation Therapy: Treatments using high-energy rays to target cancer cells and reduce tumour size are known as radiation therapy. It may be used in combination with chemotherapy for Small Cell Lung Cancer (SCLC) or to relieve symptoms in advanced-stage SCLC.
Targeted Therapy : Drugs designed for particular forms of lung cancer are used in this treatment. Targeted therapy can locate and target specific cancer cells without endangering healthy cells. Although SCLC usually doesn't exhibit specific mutations like SCLC, studies are still being conducted on targeted treatments for particular genetic changes.
Cost Start From USD 5500 - USD 54000Explore Options
Immunotherapy : It emerged as a potentially effective treatment for SCLC, particularly for patients with advanced stages of the disease or who experience a relapse following chemotherapy. The body's immune system can better identify and combat cancer cells through immunotherapy.
{immunotherapy}Chemotherapy : Chemotherapy uses medications that target lung cancer. It is among the most widely used therapies for SCLC. Chemotherapy may be prescribed by your oncologist alone or in conjunction with other treatments.
Cost Start From USD 800 - USD 6000Explore Options
A variety of imaging tests, biopsies, and other techniques are used in the diagnosis of small cell lung cancer (SCLC) to detect and stage the malignancy. These are a few typical diagnostic choices:
Imaging Studies
Biopsy
Laboratory Tests
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services to support patients through Teleconsulations and online therapy sessions.
Lifestyle changes and modification
Dietary adjustments and supplements shall make lifestyle changes and tailored meal plans to control symptoms and guarantee adequate nourishment. The practice of yoga and meditation helps reduce stress and improve mental well-being.
Lymphedema Management
Lymphatic drainage exercises promote lymphatic fluid flow away from the affected area. Our graded exercise programs allow patients to lead a dignified lifestyle.
Monitoring and follow-up
Schedule regular follow-up appointments with the oncologist to address complications, monitor recovery, and detect any signs of recurrence.
Depending on the circumstances, your doctor might recommend medication to help manage your symptoms and complement the course of treatment.









Sharjah, United Arab Emirates
Zulekha Hospital Sharjah located in Sharjah, United Arab Emirates is accredited by ISO, JCI. Also listed below are some of the most prominent infrastructural details:

Abu Dhabi, United Arab Emirates
The Hospital owns an International Patient Services Team that is responsible to assist international patients with world-class healthcare, transportation arrangement, accommodation facilities, language interpreters, and much more.
Burjeel Medical City (about 1.2 million square facilities)provides 7-star hospitality to its patients. It has the largest facility space bed among all the private hospitals. The Hospital consists of-

Dubai, United Arab Emirates
Zulekha Hospital Dubai located in Dubai, United Arab Emirates is accredited by ISO, JCI. Also listed below are some of the most prominent infrastructural details:
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
The time needed to treat small cell lung cancer (SCLC) varies in the UAE depending on the disease stage and selected treatments. Speaking with an oncologist is crucial to establish a customised treatment schedule.
In the UAE, a comprehensive strategy is used to manage the quality of life during and after small cell lung cancer (SCLC) treatment. This comprises programs for pulmonary rehabilitation aimed at improving physical function and general well-being, as well as psychological support and symptom management.
It is challenging to get precise success rates for treating non-small cell lung cancer (NSCLC) in the UAE. However, depending on the stage of diagnosis, 5-year survival rates vary significantly across the globe.
Non-small cell lung cancer (NSCLC) is the 6th most prevalent type of cancer overall in the United Arab Emirates (UAE), making it comparatively rare.
In the UAE, it is traditional practice to get a second opinion. Many hospitals and oncologists in the UAE are willing to assess cases and offer second opinions on treatment strategies. One can:
The UAE is a cost-effective choice for those seeking treatment because it provides top-notch medical care at affordable costs compared to several Western nations.
The UAE's healthcare system accepts patients from abroad and provides excellent SCLC treatments at many clinics and hospitals.